The paper detail the development and testing of engineered immunosuppressive and fibrosis-targeted dendritic cells (iCDCs) as a novel treatment for heart failure. These specialized cells are designed to home specifically to damaged heart tissue by targeting fibroblast activation protein (FAP), where they deliver a combination of immunomodulatory factors including IL-10, CTLA4-Ig, and PD-L1. Experi...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动